Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bio&Tech Smart Capital is a venture capital fund based in Santiago de Compostela, Galicia, Spain. Founded in May 2022, it is the first 100% private Galician venture capital fund specializing exclusively in Biotechnology and Life Sciences. The fund aims to facilitate the transformation of scientific knowledge into profitable companies by supporting spin-offs and startups emerging from universities and innovation laboratories. The organization is composed of experienced venture capital professionals, researchers, and entrepreneurs with a deep understanding of the biotech sector.
The fund has a target size of €50 million and aims to invest in 30-40 companies, with a significant focus on projects located in Galicia. As of November 2022, Bio&Tech Smart Capital announced its first close after raising over €5 million in its initial six months. The team maintains deal flow access across various regions, including California, Boston, New York, London, and Israel, enhancing their investment capabilities.
Bio&Tech Smart Capital focuses on investing in digital technologies applied to life sciences, biotechnology, and medical diagnostics and devices. The fund seeks to support projects that align with its expertise and demonstrate potential for social impact and profitability. Approximately 50% of their investments are directed towards projects located in Galicia, while the remaining investments target broader Spain and Europe.
The fund's investment strategy includes targeting 15-20 seed-stage projects with investment tickets ranging from €200,000 to €400,000, and 10-12 Series A projects with investment tickets between €2 million and €5 million. Bio&Tech Smart Capital emphasizes projects that can leverage the team's extensive experience and networks to facilitate market access and scaling opportunities.
Bio&Tech Smart Capital has made notable investments in the following companies:
These investments reflect the fund's commitment to supporting innovative biotech and healthcare solutions that have the potential for significant social impact.
Santi Domínguez — General Partner, Life Science & Digital Expert, Entrepreneur. He has a strong background in life sciences and digital technologies.
Pablo Álvarez — General Partner, Life Science Expert. He represents Grupo Zendal, a major Galician healthcare and pharma group.
Tomás Pérez — General Partner, CEO. He has extensive experience in venture capital and is the CEO of Noso Capital.
Daniel Prieto — General Partner, Operational & Industry 4.0 Entrepreneur. He brings expertise in operational management and industry innovation.
Álvaro Jiménez — General Partner, Life Science Expert. He has a strong focus on life sciences investments.
Ani Chahal — General Partner, Life Science Expert, Entrepreneur. She has a background in entrepreneurship and life sciences.
To pitch Bio&Tech Smart Capital, founders should submit their proposals through the fund's website. A comprehensive pitch deck is essential, including details on the technology, market analysis, and team qualifications. The fund prefers warm introductions but will consider direct submissions.
Response times can vary, but founders should expect feedback within a few weeks of submission.
In November 2022, Bio&Tech Smart Capital announced its first close after raising over €5 million in its initial six months. This milestone marked a significant step in the fund's journey to support biotech and life sciences startups.
Recently, the fund participated as a lead investor in a €1 million funding round for ADNTRO Genetics, which is developing a proprietary genetic test aimed at personalized preventive medicine recommendations.
What are Bio&Tech Smart Capital's investment criteria?
The fund focuses on seed and Series A investments in biotech, healthcare, and digital health sectors. They prioritize projects that demonstrate social impact and profitability potential.
How can founders pitch to Bio&Tech Smart Capital?
Founders can pitch their ideas through the fund's website at biotechsmartcapital.com. A well-prepared pitch deck should include details on the technology, market opportunity, and team background.
What makes Bio&Tech Smart Capital different from other VCs?
Bio&Tech Smart Capital is unique as it is the first 100% private Galician venture capital fund focused exclusively on biotechnology and life sciences, with a strong emphasis on social impact.
What is the geographic scope of Bio&Tech Smart Capital's investments?
The fund primarily invests in projects located in Galicia, with 50% of its investments directed towards this region, while also considering opportunities across Spain and Europe.
What is the typical check size for investments?
Bio&Tech Smart Capital typically invests between €200,000 and €5 million, depending on the stage of the company and the specific project.
What kind of support do portfolio companies receive?
Portfolio companies benefit from the team's extensive experience and networks, which facilitate market access and scaling opportunities, enhancing their growth potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.